推进转移性癌症的精确肿瘤学:食品药品监督管理局批准基础一液体CDx作为伴随诊断对应物。

IF 0.9 Q4 ONCOLOGY Rare Tumors Pub Date : 2023-09-25 eCollection Date: 2023-01-01 DOI:10.1177/20363613231204798
Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan
{"title":"推进转移性癌症的精确肿瘤学:食品药品监督管理局批准基础一液体CDx作为伴随诊断对应物。","authors":"Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan","doi":"10.1177/20363613231204798","DOIUrl":null,"url":null,"abstract":"malignant","PeriodicalId":46078,"journal":{"name":"Rare Tumors","volume":"15 ","pages":"20363613231204798"},"PeriodicalIF":0.9000,"publicationDate":"2023-09-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/b9/10.1177_20363613231204798.PMC10521303.pdf","citationCount":"0","resultStr":"{\"title\":\"Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence.\",\"authors\":\"Syeda Shahnoor, Manahil Mansha, Solay Farhat, Adeena Maryyum, Adil Naseer Khan, Abdul Moiz Khan\",\"doi\":\"10.1177/20363613231204798\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"malignant\",\"PeriodicalId\":46078,\"journal\":{\"name\":\"Rare Tumors\",\"volume\":\"15 \",\"pages\":\"20363613231204798\"},\"PeriodicalIF\":0.9000,\"publicationDate\":\"2023-09-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/b9/10.1177_20363613231204798.PMC10521303.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Rare Tumors\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/20363613231204798\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rare Tumors","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/20363613231204798","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/1/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Advancing precision oncology in metastatic colorectal cancer: The food and drug administration approval of foundation one liquid CDx as a companion diagnostic a correspondence.
malignant
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Rare Tumors
Rare Tumors ONCOLOGY-
CiteScore
1.50
自引率
0.00%
发文量
15
审稿时长
15 weeks
期刊最新文献
Reading level, acuity, and speed evaluation among retinoblastoma survivors: A prospective case series. A rare case of granular cell tumor affecting the upper back in a child. The efficacy of combination immunotherapy with ipilimumab plus nivolumab in metastatic myxofibrosarcoma. Surgical management of a chest wall osteosarcoma with pleural and lung invasion through en-bloc chest resection and complex reconstruction. Case report. Exploration of the causative gene in a case of multiple nevoid basal cell carcinoma: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1